Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,372 | 891 | 98.0% |
| Consulting Fee | $150.00 | 1 | 1.4% |
| Education | $63.12 | 12 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,660 | 92 | $0 (2020) |
| Novo Nordisk Inc | $1,194 | 157 | $0 (2019) |
| Lilly USA, LLC | $1,140 | 147 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $956.46 | 68 | $0 (2021) |
| PFIZER INC. | $949.50 | 132 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $729.91 | 39 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $703.03 | 56 | $0 (2020) |
| Amgen Inc. | $667.60 | 44 | $0 (2021) |
| GlaxoSmithKline, LLC. | $540.77 | 44 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $427.79 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $146.39 | 7 | Lilly USA, LLC ($45.63) |
| 2020 | $1,017 | 66 | AstraZeneca Pharmaceuticals LP ($299.55) |
| 2019 | $3,344 | 286 | AstraZeneca Pharmaceuticals LP ($494.32) |
| 2018 | $3,201 | 254 | AstraZeneca Pharmaceuticals LP ($502.32) |
| 2017 | $2,877 | 291 | SANOFI-AVENTIS U.S. LLC ($454.78) |
All Payment Transactions
904 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Cardiovascular | ||||||
| 05/17/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $31.72 | General |
| Category: Diabetes | ||||||
| 04/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: UROLOGY | ||||||
| 03/29/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Neuroscience | ||||||
| 03/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
| 12/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/12/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 11/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: DIABETES | ||||||
| 10/26/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/08/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: DIABETES | ||||||
| 09/24/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/01/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 09/01/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 529 | 625 | $103,115 | $29,863 |
| 2022 | 37 | 3,007 | 5,126 | $438,191 | $148,132 |
| 2021 | 47 | 5,666 | 11,828 | $949,779 | $384,822 |
| 2020 | 56 | 9,038 | 18,587 | $1.3M | $563,938 |
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 196 | $60,484 | $16,718 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 103 | $22,424 | $6,397 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $9,919 | $2,814 | 28.4% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 23 | 23 | $3,818 | $916.96 | 24.0% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 15 | 15 | $1,463 | $681.30 | 46.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 73 | $979.25 | $590.65 | 60.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 31 | 33 | $734.25 | $341.55 | 46.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 24 | 26 | $862.00 | $341.12 | 39.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 28 | $609.00 | $266.56 | 43.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 16 | $600.00 | $263.36 | 43.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 11 | 11 | $335.50 | $146.96 | 43.8% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 19 | 20 | $290.00 | $126.80 | 43.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 12 | 22 | $159.50 | $68.42 | 42.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 12 | 12 | $156.00 | $67.92 | 43.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 12 | 12 | $141.00 | $60.96 | 43.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 11 | 12 | $141.00 | $60.96 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 601 | $181,210 | $51,231 | 28.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 299 | 446 | $49,394 | $20,212 | 40.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 1,144 | $51,179 | $19,381 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 109 | 109 | $33,677 | $14,287 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 202 | $43,016 | $12,307 | 28.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 30 | $12,615 | $4,035 | 32.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 30 | 214 | $13,687 | $3,747 | 27.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 167 | 173 | $6,488 | $2,831 | 43.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 192 | 213 | $4,720 | $2,200 | 46.6% |
About Dr. Brian Patterson, MD
Dr. Brian Patterson, MD is a Family Medicine healthcare provider based in Bellingham, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982792131.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Patterson, MD has received a total of $10,585 in payments from pharmaceutical and medical device companies, with $146.39 received in 2021. These payments were reported across 904 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,372).
As a Medicare-enrolled provider, Patterson has provided services to 18,240 Medicare beneficiaries, totaling 36,166 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Specialist
- Location Bellingham, WA
- Active Since 10/11/2006
- Last Updated 06/02/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982792131
Products in Payments
- FARXIGA (Drug) $1,167
- TRULICITY (Drug) $888.64
- XARELTO (Drug) $853.36
- JARDIANCE (Drug) $513.34
- Tresiba (Drug) $448.42
- Trintellix (Drug) $430.55
- CHANTIX (Drug) $412.44
- Ozempic (Drug) $399.21
- BEVESPI AEROSPHERE (Drug) $349.17
- Victoza (Drug) $304.67
- LYRICA (Drug) $302.71
- ELIQUIS (Drug) $297.94
- TOUJEO (Drug) $294.25
- Aimovig (Biological) $287.23
- Prolia (Biological) $283.30
- AJOVY (Drug) $260.91
- SOLIQUA (Drug) $260.50
- ANORO (Drug) $169.66
- TROKENDI XR (Drug) $151.01
- GARDASIL (Biological) $150.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bellingham
Dr. James Moren, Md, MD
Family Medicine — Payments: $118,124
Neil Stark, D.o, D.O
Family Medicine — Payments: $8,075
Dr. Sandhya Gelou, M.d, M.D
Family Medicine — Payments: $2,506
Dr. Alexander Gelou, M.d, M.D
Family Medicine — Payments: $1,271
Jamie Kendall-Weed, M.d, M.D
Family Medicine — Payments: $1,012
Caitlin Blau, Do, DO
Family Medicine — Payments: $814.32